Hmama Z, Normier G, Kouassi E, Flacher M, Binz H, Revillard J P
INSERM U80 CNRS URA 1177 UCBL, Hôpital E. Herriot, Lyon, France.
Immunobiology. 1992 Nov;186(3-4):183-98. doi: 10.1016/S0171-2985(11)80249-4.
The binding of a membrane proteoglycan from a non-encapsulated strain of Klebsiella pneumoniae (Kp-MPG) and four derivatives thereof, to human leukocytes, was investigated by indirect immunofluorescence using biotinylated F(ab')2 fragments of anti-Kp-MPG antibodies and the streptavidin-phycoerythrin amplification system in flow cytometry. Four Kp-MPG derivatives were studied: 1/ an acylpoly(1,3)galactoside (APG), 2/ an APG preparation submitted to acid hydrolysis which removed all fatty acids, but left intact the galactose chain of APG (GC-APG), 3/ a preparation obtained by mild alkaline hydrolysis, containing additional ester-linked C14 and C16 fatty acids bound to the APG molecule (EFA-APG) and 4/ a polymer of the latter compound (APG pol). Kp-MPG, APG and EFA-APG were shown to bind exclusively to monocytes at the lowest concentrations (from 0.15 to 3 microM APG). At higher concentrations, these compounds interacted with polymorphonuclear leukocytes, and with lymphocyte subsets in the following decreasing order: B cells, NK cells, CD8+ and CD4+ lymphocytes. Neither APG pol or GC-APG nor K. pneumoniae smooth LPS showed significant binding to leukocytes. However Kp-LPS treated by drastic alkaline hydrolysis displayed binding properties similar to those of APG. Removal of the ester-linked C14 and C16 fatty acids from EFA-APG did not affect the binding of the molecule. The capacity of cells from the myelomonocytic lineage to bind Kp-MPG and APG was very low in phenotypically immature cell lines (HL60 and U937) as compared with monocytes or polymorphonuclear cells. Treatment of U937 cells with interferon-gamma up-regulated their APG binding capacity along with the expression of the integrin CD 11 b and the CD 14 molecule, whereas monocytes exposed to interferon-gamma showed an increased binding of APG associated with an elevated expression of the galactose specific lectin Mac-2. The data demonstrate a preferential binding of Kp-MPG and APG to cells of the monocyte/macrophage lineage. APG binding does not involve the poly (1,3) galactose chain and the ester-linked C14 and C16 fatty acids but requires the presence of the hydrophobic part of the molecule.
利用抗肺炎克雷伯菌膜蛋白聚糖(Kp-MPG)抗体的生物素化F(ab')2片段和链霉亲和素-藻红蛋白放大系统,通过间接免疫荧光法在流式细胞术中研究了一株非包膜型肺炎克雷伯菌的膜蛋白聚糖(Kp-MPG)及其四种衍生物与人白细胞的结合情况。研究了四种Kp-MPG衍生物:1/ 酰基聚(1,3)半乳糖苷(APG),2/ 经过酸水解的APG制剂,其去除了所有脂肪酸,但保留了APG的半乳糖链完整(GC-APG),3/ 通过温和碱水解获得的制剂,含有与APG分子结合的额外酯连接的C14和C16脂肪酸(EFA-APG),4/ 后一种化合物的聚合物(APG pol)。结果显示,Kp-MPG、APG和EFA-APG在最低浓度(0.15至3 microM APG)时仅与单核细胞结合。在较高浓度下,这些化合物与多形核白细胞相互作用,与淋巴细胞亚群的相互作用顺序如下:B细胞、NK细胞、CD8+和CD4+淋巴细胞。APG pol、GC-APG或肺炎克雷伯菌光滑型脂多糖均未显示出与白细胞的显著结合。然而,经过剧烈碱水解处理的Kp-LPS表现出与APG相似的结合特性。从EFA-APG中去除酯连接的C14和C16脂肪酸并不影响该分子的结合。与单核细胞或多形核细胞相比,在表型不成熟的细胞系(HL60和U937)中,骨髓单核细胞系细胞结合Kp-MPG和APG的能力非常低。用γ干扰素处理U937细胞上调了它们的APG结合能力以及整合素CD 11 b和CD 14分子的表达,而暴露于γ干扰素的单核细胞显示出APG结合增加,同时半乳糖特异性凝集素Mac-2的表达升高。数据表明Kp-MPG和APG优先与单核细胞/巨噬细胞系细胞结合。APG的结合不涉及聚(1,3)半乳糖链以及酯连接的C14和C16脂肪酸,但需要分子中疏水部分的存在。